15th Annual Structural Heart Summit Will Feature Latest Research and Techniques
NEW YORK – May 10, 2022 – The program for TVT 2022: The Structural Heart Summit is now available online. An annual meeting from the Cardiovascular Research Foundation (CRF), TVT features cutting-edge research and techniques for structural heart interventions and will take place June 8-10, 2022 at the Sheraton Grand Chicago Riverwalk in Chicago, Illinois.
2022 marks the 20th anniversary of transcatheter aortic valve replacement (TAVR). Transcatheter valve therapy has evolved from a novel therapy for the sickest patients to the standard of care for many with aortic stenosis. The TVT meeting has played a critical role in the development of the field and has grown to reflect the changing landscape of treating structural heart disease via TAVR and transcatheter mitral and tricuspid therapies.
The treatment of structural heart disease is multidisciplinary, integrating noninvasive cardiac imaging, surgical therapies, heart failure management, and novel transcatheter approaches. TVT will focus on the evaluation and management of patients, imaging modalities, current and future therapeutic options, and skills needed to perform TAVR, left atrial appendage (LAA) closure, and patent foramen ovale (PFO) closure.
More than 25 live cases from 10 leading academic medical centers in North America and Europe will be presented. The meeting includes an imaging track with six dedicated imaging sessions and imaging will be highlighted in other sessions. The course will also showcase late-breaking clinical science, structural innovation sessions, device-specific training opportunities, and deep-dives on technique and procedural decision-making. For 15 years, TVT has provided healthcare professionals with the latest advances, tools, and techniques for the treatment of valvular heart disease using nonsurgical procedures.
Additional information on TVT is available at https://tvt2022.crfconnect.com/.